rescription drug giant GlaxoSmithKline agreed to pay a record $3 billion fine to settle a litany of charges stemming from the company's illegal promotion of its products. Among other criminal complaints, federal prosecutors had accused GlaxoSmithKline of promoting the anti-depression drug Paxil for children, even though the FDA had never approved Paxil for patients under 18. GlaxoSmithKline was also accused of bribing physicians to prescribe its products, part of a web of mutual back-scratching that critics say has compromised the prescription drug market.
- Which professions have the most psychopaths?
- There is a better alternative to raising the minimum wage
- 'Tis the season for having sex with old flames and ruining your office reputation
- 6 grammar points to watch out for in Christmas songs
- 7 grammar rules you really should pay attention to
- Rick Santorum wins the prize for the worst Nelson Mandela tribute
- This is how much extra it costs to eat healthy every day
- 10 things you need to know today: December 8, 2013
- 7 health benefits of playing video games
- How the strange case of Obama's Uncle Omar complicates immigration reform
Subscribe to the Week